NANCY HUNTER: Open Payments
NPI 1538539143 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 53 payments from 18 companies in 2025. Trend: 2023 $1,045 · 2024 $1,293 · 2025 $1,111
Food & beverage: $1,111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $221 |
| PFIZER INC. | 8 | $159 |
| Amgen Inc. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Lundbeck LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Lilly USA, LLC | 3 | $49 |
| Insulet Corporation | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $46 |
Products named: REXULTI, NURTEC ODT, QULIPTA, TRELEGY ELLIPTA, OTEZLA, VRAYLAR, MOUNJARO, Omnipod.
Industry payments across ID — which companies pay providers there.
